CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Heart Failure and Atrial Fibrillation, Like Fire and Fury Percutaneous Atriotomy for Levoatrial–to–Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure Heart Failure With Improved Ejection Fraction-Is it Possible to Escape One’s Past? Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors Association of Cardiovascular Disease With Respiratory Disease Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) Dilated cardiomyopathy: so many cardiomyopathies!

Original Research2015 Jan 20;131(3):269-79.

JOURNAL:Circulation. Article Link

Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction

Shah SJ, Katz DH, Selvaraj S et al. Keywords: cluster analysis; echocardiography; heart failure, diastolic; patient outcome assessment

FULL TEXT PDF